TW200514554A - An ophthalmic composition for treating lacrimal fluid abnormal - Google Patents

An ophthalmic composition for treating lacrimal fluid abnormal

Info

Publication number
TW200514554A
TW200514554A TW093130064A TW93130064A TW200514554A TW 200514554 A TW200514554 A TW 200514554A TW 093130064 A TW093130064 A TW 093130064A TW 93130064 A TW93130064 A TW 93130064A TW 200514554 A TW200514554 A TW 200514554A
Authority
TW
Taiwan
Prior art keywords
lacrimal fluid
ophthalmic composition
dry eye
fluid abnormal
abnormal
Prior art date
Application number
TW093130064A
Other languages
English (en)
Inventor
Yuzuru Umeda
Hideo Nakashima
Michiko Shibuya
Yasukazu Saitoh
Shoji Okada
Shigeru Nakamura
Original Assignee
Ophtecs Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ophtecs Corp filed Critical Ophtecs Corp
Publication of TW200514554A publication Critical patent/TW200514554A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW093130064A 2003-10-06 2004-10-05 An ophthalmic composition for treating lacrimal fluid abnormal TW200514554A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003346858 2003-10-06

Publications (1)

Publication Number Publication Date
TW200514554A true TW200514554A (en) 2005-05-01

Family

ID=34419564

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093130064A TW200514554A (en) 2003-10-06 2004-10-05 An ophthalmic composition for treating lacrimal fluid abnormal

Country Status (7)

Country Link
US (1) US8541468B2 (zh)
EP (1) EP1674091B1 (zh)
JP (1) JP4249185B2 (zh)
CN (1) CN1863522A (zh)
CA (1) CA2541302A1 (zh)
TW (1) TW200514554A (zh)
WO (1) WO2005032534A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053982A1 (fr) 2006-10-30 2008-05-08 Ophtecs Corporation Composition pour le traitement de l'allergie
EP3177284B1 (en) 2014-07-21 2020-01-15 Oulun Yliopisto Oligomeric forms of 3-hydroxybutyrate
US10588877B2 (en) 2016-07-21 2020-03-17 Savind, Inc. Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116868A (en) * 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
JPH06345653A (ja) 1993-06-08 1994-12-20 Asahi Chem Ind Co Ltd 点眼液
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
JPH10265378A (ja) * 1997-03-25 1998-10-06 Ofutekusu:Kk 角膜上皮損傷治療剤
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
JP3228699B2 (ja) 1997-04-22 2001-11-12 株式会社オフテクス 眼手術用灌流液製剤
US6495598B1 (en) * 1997-04-22 2002-12-17 Ophtecs Corporation Perfusate preparation for ophthalmic operation
JP2000281563A (ja) 1999-03-29 2000-10-10 Asahi Chem Ind Co Ltd 眼科用液剤
BR0011225A (pt) 1999-04-30 2002-03-19 Sucampo Ag Agente para tratar de olhos secos, seu método e uso
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
JP2001089366A (ja) * 1999-09-14 2001-04-03 Ophtecs Corp 角膜混濁抑制剤
US6569903B2 (en) 1999-12-07 2003-05-27 Rohto Pharmaceutical Co., Ltd. Ophthalmic compositions
KR100550023B1 (ko) * 2000-01-11 2006-02-09 가부시키가이샤 오프테꾸스 눈 수술용 관류액 제제
JP2003313124A (ja) * 2002-02-20 2003-11-06 Ophtecs Corp アポトーシスに起因するドライアイにより生じる眼障害の予防および／または治療のための組成物
JP2003313123A (ja) * 2002-02-20 2003-11-06 Ophtecs Corp アポトーシスによる眼の障害（ドライアイによる障害を除く）の予防および／または治療のための組成物

Also Published As

Publication number Publication date
JPWO2005032534A1 (ja) 2006-12-14
CN1863522A (zh) 2006-11-15
EP1674091B1 (en) 2014-04-23
EP1674091A4 (en) 2009-09-02
JP4249185B2 (ja) 2009-04-02
EP1674091A1 (en) 2006-06-28
CA2541302A1 (en) 2005-04-14
US20070225369A1 (en) 2007-09-27
WO2005032534A1 (ja) 2005-04-14
US8541468B2 (en) 2013-09-24

Similar Documents

Publication Publication Date Title
TW200714277A (en) Methods and compositions for altering cell fuction
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
WO2007099398A3 (en) Methods and compositions for treatment of skin
BRPI0520014A2 (pt) emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco
CL2007002705A1 (es) Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm.
PL1910338T3 (pl) Związki heterotetracykliczne jako mimetyki TPO
WO2006078576A3 (en) Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0710085B8 (pt) composições oftálmicas e seus kits
MX2009003378A (es) Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos.
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
WO2008127680A3 (en) Diagnosis and treatment of diseases caused by misfolded proteins
EP1870099A4 (en) PROTECTIVE AGENT FOR RETINAL NEURAL CELL COMPRISING AN INDAZOLE DERIVATIVE AS ACTIVE INGREDIENT
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
WO2007015175A3 (en) Use of pp-1 inhibitors to prevent missplicing events
GB0514811D0 (en) Compounds
BRPI0606336A2 (pt) composição para tratamento de lentes de contato, uso de uma composição, método para a purificação de lentes de contato, solução de multiuso e kit
TW200514554A (en) An ophthalmic composition for treating lacrimal fluid abnormal
EA201000432A1 (ru) Фунгицидные смеси тритиконазола и дифеноконазола
MX2009009409A (es) Compuestos que tienen estructura aril-sulfonamidica utiles como inhibidores de metaloproteasas.
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
EA200702479A1 (ru) Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов